FDA Inspection 1313148 — Mirta Isabel Acuna, MD

Mirta Isabel Acuna, MD — FEI 3040514515

The FDA completed an inspection of Mirta Isabel Acuna, MD on March 13, 2026 in Santiago. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 13, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Santiago (Chile)

Additional Details

Clinical Investigator (CI)